Use and Misuse of GLP-1 Receptor Agonists Among People With Eating Disorders

  • Peiper N
  • Zibbell J
  • LaJoie A
  • et al.
0Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.
Get full text

Abstract

This cross-sectional study evaluates the prevalence of glucagon-like peptide-1 (GLP-1) receptor agonist use and misuse among people with eating disorders in the US.

Cite

CITATION STYLE

APA

Peiper, N. C., Zibbell, J. E., LaJoie, A. S., Wahlang, B., Krishnasamy, S. S., & Levinson, C. A. (2026). Use and Misuse of GLP-1 Receptor Agonists Among People With Eating Disorders. JAMA Psychiatry. https://doi.org/10.1001/jamapsychiatry.2026.1716

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free